NCT02215850View on ClinicalTrials.gov

Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Solid Tumours
Interventions
DRUG

SLC-0111

Trial Locations (3)

T6G 1Z2

Alberta Health Services - Cross Cancer Institute, Edmonton

V5Z 4E6

British Columbia Cancer Agency, Vancouver

M5G 2M9

Princess Margaret Cancer Centre, Toronto

Sponsors

Collaborators (1)

Ozmosis Research Inc.
All Listed Sponsors
collaborator

Ozmosis Research Inc.

INDUSTRY

lead

Welichem Biotech Inc.

INDUSTRY